These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6340700)

  • 1. The treatment of angina pectoris with the new beta-receptor blocker carteolol. Results of a controlled trial in comparison with pindolol.
    Simon H; Schuppan U
    Arzneimittelforschung; 1983; 33(2a):318-21. PubMed ID: 6340700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical experiences in patients with coronary heart disease and angina pectoris].
    Sölter H
    Arzneimittelforschung; 1983; 33(2a):304-10. PubMed ID: 6404286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experiences with carteolol in patients with essential hypertension].
    Viehmann P
    Arzneimittelforschung; 1983; 33(2a):322-5. PubMed ID: 6340701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Heart rate behavior and the ischemic ST-segment under carteolol hydrochloride. Dose-response relationship and duration of effect].
    Kober G; Veidt J; Mikludy R; Kaltenbach M
    Arzneimittelforschung; 1983; 33(2a):313-7. PubMed ID: 6682323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of intrinsic sympathomimetic activity of the beta blocker carteolol. II: Comparative studies of carteolol and pindolol in patients with bradycardia].
    Lohmöller G; Middeke M; Mrowka C; Pötzl C; Renner W; Zoller W
    Med Klin (Munich); 1989 Feb; 84(2):81-5. PubMed ID: 2651861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of carteolol and nadolol in the treatment of stable angina pectoris.
    Luther RR; Glassman HN; Jordan DC
    J Clin Pharmacol; 1988 Jul; 28(7):634-9. PubMed ID: 3063728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment of angina pectoris with carteolol: a new beta-adrenergic receptor blocking agent.
    Luther RR; Glassman HN; Jordan DC; Klepper MJ
    J Int Med Res; 1986; 14(4):167-74. PubMed ID: 3093295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical results with carteolol in patients with arrhythmias].
    Strösser W
    Arzneimittelforschung; 1983; 33(2a):339-45. PubMed ID: 6682327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypotensive effect of carteolol in patients with essential hypertension].
    Beythien RD
    Arzneimittelforschung; 1983; 33(2a):330-3. PubMed ID: 6682325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Carteolol in essential hypertension. Dose range study and controlled open trial in comparison with pindolol].
    Werning C
    Arzneimittelforschung; 1983; 33(2a):325-30. PubMed ID: 6682324
    [No Abstract]   [Full Text] [Related]  

  • 11. [Beta-blockader, pindolol, in the therapy of angina pectoris; a report on a multicentric controlled study].
    Lang E; Fitscha P; Schiess W
    Wien Med Wochenschr; 1979 Sep; 129(17):484-8. PubMed ID: 120078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized double-blind study of pindolol in patients with stable angina pectoris.
    Harston WE; Friesinger GC
    Am Heart J; 1982 Aug; 104(2 Pt 2):504-11. PubMed ID: 7102537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of angina pectoris with pindolol: the significance of intrinsic sympathomimetic activity of beta blockers.
    Kostis JB; Frishman W; Hosler MH; Thorsen NL; Gonasun L; Weinstein J
    Am Heart J; 1982 Aug; 104(2 Pt 2):496-504. PubMed ID: 7102536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemodynamic studies at rest and under stress in patients with coronary heart disease after administration of carteolol].
    Saborowski F; Dundalek E; Griebenow R; Sy M
    Arzneimittelforschung; 1983; 33(2a):310-2. PubMed ID: 6682322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia.
    Cocco G; Strozzi C; Chu D; Amrein R; Castagnoli E
    Eur J Cardiol; 1979 Jul; 10(1):59-69. PubMed ID: 111940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A comparative study of carteolol and propranolol on exercise performance in patients with chronic stable angina pectoris].
    Liu PH; Lai WY; Chen CY; Shieh SM
    Taiwan Yi Xue Hui Za Zhi; 1985 Apr; 84(4):457-61. PubMed ID: 3860617
    [No Abstract]   [Full Text] [Related]  

  • 17. Antianginal effects of atenolol and pindolol in patients with stable effort angina pectoris.
    Antalóczy Z; Kekes E
    Zhongguo Yao Li Xue Bao; 1989 May; 10(3):222-6. PubMed ID: 2609991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a combination of pindolol and isosorbide dinitrate on ischemic ST-segment depression and exercise ability in angina pectoris.
    Dorow P; Schiess W
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):419-22. PubMed ID: 6386704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability of response to beta receptor blockade for angina pectoris in clinical trials: a study of pindolol.
    Harston WE; Friesinger GC
    Am J Cardiol; 1982 Oct; 50(4):722-7. PubMed ID: 6127028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intravenous and oral pindolol on exercise tolerance and electrocardiographic changes in angina pectoris.
    Storstein L
    J Cardiovasc Pharmacol; 1980; 2(6):739-50. PubMed ID: 6160324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.